Tevis Investment Management Gilead Sciences, Inc. Transaction History

Tevis Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $11,372 - $12,989	191 Added 17.97%	1,254 $77,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $3,232 - $3,640	56 Added 5.56%	1,063 $63,000
Q1 2022 Aug 05, 2022	BUY	$57.92 - $72.58 $25,021 - $31,354	432 Added 75.13%	1,007 $59,000
Q4 2021 Aug 05, 2022	BUY	$64.88 - $73.64 $37,306 - $42,343	575 New	575 $42,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

Stay updated on Tevis Investment Management with notifications on news.